This surgical robotics firm develops minimally invasive systems for urologic procedures, targeting hospitals and specialty clinics.

View PROCEPT BioRobotics Corp. PRCT stock quote prices, financial information, real-time forecasts, and company news from CNN.

Procept Biorobotics Corp (NASDAQ:PRCT) is one of the best small cap robotics stocks to buy according to analysts. The Street ...

Throughout the last three months, 4 analysts have evaluated PROCEPT BioRobotics (NASDAQ:PRCT), offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the ...

PROCEPT BioRobotics PRCT is gearing up to announce its quarterly earnings on Wednesday, 2025-08-06. Here's a quick overview of what investors should know before the release. Analysts are estimating ...

Throughout the last three months, 7 analysts have evaluated PROCEPT BioRobotics (NASDAQ:PRCT), offering a diverse set of opinions from bullish to bearish. The table below offers a condensed view of ...

The latest price target for PROCEPT BioRobotics (NASDAQ:PRCT) was reported by Truist Securities on December 18, 2025. The analyst firm set a price target for $47.00 expecting PRCT to rise to within 12 ...

PROCEPT BioRobotics (NASDAQ:PRCT) reported first-quarter 2026 revenue of $83.1 million, up 20% year over year, as management pointed to early progress from organizational changes aimed at improving ...

"We began 2025 with strong performance, delivering total revenue growth of 55% in the first quarter. Procedural momentum remained robust heading into the second quarter, reinforcing our confidence ...

SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE)-- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company”), a surgical robotics company focused on advancing patient care by developing ...

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic ...